Encephalitis, tick borne

Active ingredient description

Encephalitis, tick borne suspension for injection is indicated for the active (prophylactic) immunization of persons of 16 years of age and older against tick-borne encephalitis (TBE). Its pharmacodynamic effect consists of the induction of a sufficiently high concentration of anti-TBE antibody to provide protection against the TBE virus.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J07BA01 Encephalitis, tick borne, inactivated, whole virus J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BA Encephalitis vaccines
Discover more medicines within J07BA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
TICOVAC Suspension for injection in a pre-filled syringe Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

External identifiers

DrugBank Drug: DB16611
UNII Identifier: 42XD79UQQ6
TICK-BORNE ENCEPHALITIS PURIFIED ANTIGEN (FORMALDEHYDE INACTIVATED)

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.